The illegal production of synthetic drugs (e.g. amphetamines, MDMA/ecstasy, methamphetamine) poses significant environmental risks, including soil and water contamination.
In this video, Ivana Obradovic, OFDT Deputy Director, discusses the legalisation of cannabis, outlining its objectives and challenges in the United States and Canada.
For the past two decades the Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD) conducted by the OFDT has made it possible to quantify the use of psychoactive substance by 17-year-olds at a regional level.
Based on a research work coordinated by the OFDT, this issue of Tendances shows that cannabis regulation raised both traditional drug policy implementation challenges and unique challenges.
Based on a research work coordinated by the OFDT, this issue of Tendances describes the structure and methods of cannabis regulation from a public health perspective, comparing six jurisdictions in the United States (Washington State, Oregon, California) and Canada (British Columbia, Ontario, Quebec).
Behavioural addictions still make up a scientific and clinical field under construction, characterised by a low consensus level which results in large numbers of concepts, terms, definitions and measuring tools.
In the 2000s, Brazil was confronted with the expansion of crack cocaine use, particularly among disadvantaged groups in its main urban centres.
Among the range of cannabis regulatory systems introduced in North America, the example of British Columbia demonstrates a cautious regulatory approach, centred on the gradual introduction of cannabis on the market, which is designed to be reasonable and guided by a step-by-step evaluation of the reform.
Canada legalised cannabis for non-medical use in October 2018. While the federal government organises the production of cannabis, it has left it up to its 13 provinces and territories to define a distribution and retail model. Ontario, the most populous province and largest cannabis market in Canada, is at the forefront of this process.
Quebec was one of the most reluctant provinces when the federal government announced its decision to legalise cannabis for non-medical use.
In the general context of a background of booming global cocaine production, this Théma report provides an assessment of the situation in France.
What is 3-MMC? What do the analyses of the SINTES network reveal? What are the uses observed by TREND?
How does the OFDT conduct surveys with its European partners?
Unlike in other parts of the world, poppy cultivation and opium use are recent phenomena in Mexican history.
Two major surveys, conducted every 4 years for the past 25 years in the adolescent population, allow for an international comparison of drug use.
This thirteenth issue of Drugs, International Challenges is devoted to the prevailing situation in terms of drug trafficking, drug use and public policies in Georgia, a Caucasian country with a population of 3.7 million.
This is a review and synthesis of the scientific literature on public health effects of liberalization of marijuana prohibition in the United States.
This report summarizes eight years of policy and public health knowledge since Colorado and Washington became the first states in the U.S. – and the first jurisdictions in the world – to begin to develop and implement policies around a commercial marketplace for marijuana.
This report analyzes the regulation of cannabis in Canada, as well as the political, economic and social impact of the policies adopted.
Based mainly on data published by the WHO, this note aims to provide an overview of the main legislative and regulatory measures taken by the different EU countries to reduce harmful alcohol consumption.